Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Emmaus Life Sciences's enterprise value was $701.41K on Oct 19, 2026, against -$292.05K a year earlier. Over the last 5 years it ranged from -$1.56M to $103.70M, with a median of $3.95M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $701.41K | +30.6% |
| 2025 | Dec 31, 2025 | $537.25K | – |
| 2024 | Dec 31, 2024 | -$712.14K | -118.4% |
| 2023 | Dec 29, 2023 | $3.86M | -67.0% |
| 2022 | Dec 30, 2022 | $11.72M | -85.4% |
| 2021 | Dec 31, 2021 | $80.03M | +44.7% |
| 2020 | Dec 31, 2020 | $55.31M | +48.3% |
| 2019 | Dec 31, 2019 | $37.29M | +177.6% |
| 2018 | Dec 31, 2018 | $13.43M | -83.7% |
| 2017 | Dec 29, 2017 | $82.26M | – |
| 2016 | Dec 30, 2016 | -$275.94K | -101.5% |
| 2015 | Dec 31, 2015 | $18.01M | -86.7% |
| 2014 | Dec 31, 2014 | $135.71M | -31.8% |
| 2013 | Dec 31, 2013 | $199.00M | +3474.1% |
| 2012 | Dec 31, 2012 | $5.57M | -83.4% |
| 2011 | Dec 30, 2011 | $33.62M | -75.0% |
| 2010 | Dec 31, 2010 | $134.43M | – |
See a number that looks wrong?